AzTrials
AzTrials

Acute CholecystitisPCNCT04979936

Early Laparoscopic Cholecystectomy Versus Percutaneous Cholecystostomy in Grade II Acute Cholecystitis Guidelines

A study testing laparoscopic cholecystectomy and percutaneous cholecystostomy in people with Acute Cholecystitis and Empyema, Gallbladder, run by Alexandria University at 2 sites in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to compare between early laparoscopic cholecystectomy versus percutaneous cholecystostomy followed by delayed interval laparoscopic cholecystectomy as regards the operative and postoperative complications Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Acute Cholecystitis, Empyema, Gallbladder
What is being tested?
laparoscopic cholecystectomy and percutaneous cholecystostomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
220 participants
Where
2 sitesEgypt
Study dates
1 Jan 2016to 31 Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients with one of the criteria stated by grade II (moderate) Tokyo guidelines for acute cholecystitis who were managed either by early LC or by a bridging PC followed by delayed LC.

Who cannot join

  • grade I or III acute cholecystitis
  • common bile duct stones or jaundice,
  • Liver cirrhosis,
  • severe upper abdominal adhesions,
  • acalculous cholecystitis
  • major comorbidities in which laparoscopic surgery is contraindicated.
  • those who followed a conservative treatment for acute cholecystitis

Trial locations and contacts

2 sites in 1 country.

Egypt2 sites
  • Alexandria university

    Alexandria

  • Faculty of Medicine

    Alexandria

Other trials in Egypt

About this study

Official title: Early Laparoscopic Cholecystectomy Versus Percutaneous Cholecystostomy Followed by Delayed Laparoscopic Cholecystectomy in Patients With Grade II Acute Cholecystitis According to Tokyo Guidelines

The aim of this study is to compare between early laparoscopic cholecystectomy versus percutaneous cholecystostomy followed by delayed interval laparoscopic cholecystectomy as regards the operative and postoperative complications

Read the detailed description

A-Study setting: Department of Surgery, main university hospital, Faculty of Medicine, Alexandria University, Egypt. The study was approved by the Ethics Committee of our institution.

B-Study design: Retrospective clinical trial C-Study subjects: The target population are patients with preoperative diagnosis of grade II acute cholecystitis Those patients were subjected to surgery either early laparoscopic cholecystectomy or delayed laparoscopic cholecystectomy after percutaneous cholecystostomy

Inclusion criteria of the study patients:

-Specific written informed consent approved by our Institution's Ethics Committee was obtained from all the treated patients.

Exclusion criteria:

-contraindication to laparoscopy,Refusal of study participation, cirrhosis, grade I or III acute cholecystitis D-Sample size calculation: a minimum sample size required per group is 88 to detect decline in the proportion of the primary outcome from 20% to 5%, at 5% level of significance and 80% power.

E-Sampling technique: By using eligibility criteria, 220 patients that were planned to undergo laparoscopic Cholecystectomy were randomly selected from the surgery department in main university hospital, Faculty of Medicine, Alexandria University. They were randomly separated into two groups:

An experiment group: (90 patients) underwent percutaneous cholecystostomy followed by delayed interval laparoscopic cholecystectomy A control group: (130 patients) underwent early laparoscopic cholecystectomy. All the participants were initially evaluated and re-evaluated during follow up period of 30 days for the outcome measures. Non blinded trial was done due to difficulty in using blinding in operative intervention.

Methods: every patient in the study sample was subjected to the followings:

  1. History
  2. Examination:
  3. Investigations ( pre and postoperative): Laboratory: WBC, CRP, lever functions Radiologic imaging: ultrasonography, CT abdomen
  4. Intervention: An experiment group: underwent percutaneous cholecystostomy followed by delayed interval laparoscopic cholecystectomy. A control group: underwent early laparoscopic cholecystectomy. Surgical Technique: laparoscopic cholecysctomy Postoperative Course: post-operative complications
  5. Outcome Measurement and Follow-Up
  • Follow up period: both groups were re-evaluated at 1, 2, 6 months. They were evaluated for the positive and negative outcome measures. There were no cases lost to follow up.
  • Outcome measures that were assessed after the follow up period were:
  • Primary outcome measures: operative and postoperative complications as conversion, biliary injury, bowel injury, they were assessed by clavien dindo classification
  • Secondary Outcome measures: ASA score, Tokyo score and some investigations.

Statistical analysis Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS) version 20 software (SPSS, Inc., Chicago, IL, USA). Quantitative variables were summarized using mean and standard deviation after data exploration using the Kolmogorov- Smirnov test. Qualitative variables were described using number and percent. Associations between the two groups and other categorical variables were assessed using Chi-square test (Fisher or Monte Carlo). Comparisons between the two groups as regards the quantitative variables were assessed using Student t-test. All Statistical tests were done at 5% level of Significance.

Risk estimates were calculated as Relative risk, Absolute risk reduction, Number needed to treat and population Attributable Risk percentage to detect the risk of development of the intraoperative and postoperative complications in the intervention and control group.

Being tested
laparoscopic cholecystectomy, percutaneous cholecystostomy
Keywords
moderate acute cholecystitis, percutaneous cholecystostomy
Medical subject headings
Cholecystitis, Acute, Cholecystitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • laparoscopic cholecystectomyProcedure or surgery

  • percutaneous cholecystostomyProcedure or surgery

Study groups in NCT04979936
Study groupRoleWhat they receive
early laparoscopic cholecystectomyActive comparatorearly laparoscopic cholecystectomy
Receives: Procedure: laparoscopic cholecystectomy
percutaneous cholecystostomyActive comparatorpercutaneous cholecystostomy first followed by delayed laparoscopic cholecystectomy
Receives: Procedure: percutaneous cholecystostomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. operative difficulties as conversion, operative time, biliary injury

    as assessed by the main surgeon

    Measured: at the time of cholecysctomy

  2. postoperative complications

    as assessed by clavien dindo classification

    Measured: 30 days after the operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2021
  2. Study start1 Jan 2016
  3. Primary completion31 Jan 2021
  4. Study completion31 Jan 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
220 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04979936
Sponsor's protocol ID
17/11
Acronym
PC
Status last verified
Jul 2021
First submitted
17 Jul 2021
Last updated
28 Jul 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: data extracted from the hospital records. it is difficult to bring these data into public

Questions about this trial

What is this clinical trial studying?

A study testing laparoscopic cholecystectomy and percutaneous cholecystostomy in people with Acute Cholecystitis and Empyema, Gallbladder, run by Alexandria University at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

operative difficulties as conversion, operative time, biliary injury (time frame: at the time of cholecysctomy). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in